Medibank stock has its November 18, 2026 annual meeting

Published on 10/17/2026 at 21:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal 2026 revenue rose 8.60 percent to AUD 9.29 billion. Medibank stock last stood at AUD 4.74 on October 16, 2026, down 0.84 percent versus ASX close.

Annual meeting and valuation

Medibank will hold its annual general meeting on November 18, 2026.
Fiscal 2026 revenue rose 8.60 percent to AUD 9.29 billion.
Medibank stock was last at AUD 4.74 on October 16, 2026, down 0.84 percent versus the ASX close.
Medibank traded at a price-to-earnings ratio of 20.61 on October 16, 2026.

Medibank, AU000000MPL3, Illustration mit AI erstellt.

Medibank's annual general meeting will take place on November 18, 2026, according to Simply Wall St in an update dated September 21, 2026. The date gives investors a defined governance checkpoint after a fiscal year in which revenue and earnings both increased. Medibank stock was last at AUD 4.74 on October 16, 2026 at 4:19 p.m. AEDT, down 0.84 percent from the ASX prior close of AUD 4.78.

Fiscal 2026 revenue reached AUD 9.29 billion

Simply Wall St reported that Medibank's fiscal 2026 revenue reached AUD 9.29 billion, an 8.60 percent increase from fiscal 2025. Net income rose 28.00 percent to AUD 638.70 million, while earnings per share increased to AUD 0.23 from AUD 0.18. The comparison matters because the revenue gain was accompanied by a larger increase in net income.

Stock remains below its yearly high

The last ASX price of AUD 4.74 sat between the 52-week low of AUD 4.06 and the 52-week high of AUD 5.31 on October 16, 2026. That placed the stock 10.73 percent below the high and 16.75 percent above the low. The session range ran from AUD 4.73 to AUD 4.81, while volume reached 9,094,153 shares against an average of 6,850,192 shares.

For investors, the range frames the stock more clearly than the single-day decline. Medibank ended the session 0.84 percent below its prior ASX close, while the latest price remained 10.73 percent below the yearly peak.

Valuation stays tied to earnings

Medibank had a market capitalization of AUD 13.10 billion and a price-to-earnings ratio of 20.61 as of October 16, 2026. The valuation figure sits alongside fiscal 2026 net income of AUD 638.70 million, linking the market value to a reporting period rather than to an undated estimate.

The November 18, 2026 annual general meeting is the next dated corporate event highlighted in the recent company calendar. It follows the fiscal 2026 reporting period ended June 30, 2026 and gives shareholders the next formal date for governance updates.

Price position in Australia

Medibank is listed on the Australian Securities Exchange under ticker MPL and operates in health insurance. Its last quoted price of AUD 4.74 on October 16, 2026 was accompanied by a daily decline of 0.84 percent, with the stock still above its 52-week low and below its 52-week high.

The last available ASX price was AUD 4.74 on October 16, 2026 at 4:19 p.m. AEDT, down 0.84 percent versus the ASX prior close of AUD 4.78.